Annual EBIT
-$20.24 M
+$20.28 M+50.05%
December 31, 2023
Summary
- As of February 23, 2025, WINT annual earnings before interest & taxes is -$20.24 million, with the most recent change of +$20.28 million (+50.05%) on December 31, 2023.
- During the last 3 years, WINT annual EBIT has risen by +$12.20 million (+37.61%).
- WINT annual EBIT is now -743.38% below its all-time high of -$2.40 million, reached on December 31, 1995.
Performance
WINT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$2.94 M
+$8.78 M+74.93%
September 30, 2024
Summary
- As of February 23, 2025, WINT quarterly earnings before interest & taxes is -$2.94 million, with the most recent change of +$8.78 million (+74.93%) on September 30, 2024.
- Over the past year, WINT quarterly EBIT has stayed the same.
- WINT quarterly EBIT is now -128.40% below its all-time high of $10.35 million, reached on March 31, 2024.
Performance
WINT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$9.45 M
+$1.47 M+13.49%
September 30, 2024
Summary
- As of February 23, 2025, WINT TTM earnings before interest & taxes is -$9.45 million, with the most recent change of +$1.47 million (+13.49%) on September 30, 2024.
- Over the past year, WINT TTM EBIT has stayed the same.
- WINT TTM EBIT is now -3050.33% below its all-time high of -$300.00 thousand, reached on March 31, 1995.
Performance
WINT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
WINT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.0% | 0.0% | 0.0% |
| 3 y3 years | +37.6% | 0.0% | 0.0% |
| 5 y5 years | -5.8% | 0.0% | 0.0% |
WINT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.9% | -128.4% | +83.0% | -63.1% | +87.8% |
| 5 y | 5-year | at high | +73.9% | -128.4% | +93.6% | -63.1% | +87.8% |
| alltime | all time | -743.4% | +73.9% | -128.4% | +93.6% | -3050.3% | +87.8% |
Windtree Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.94 M(-74.9%) | -$9.45 M(-13.5%) |
| Jun 2024 | - | -$11.72 M(-213.3%) | -$10.93 M(+88.5%) |
| Mar 2024 | - | $10.35 M(-301.2%) | -$5.80 M(-71.4%) |
| Dec 2023 | -$20.24 M(-50.0%) | -$5.14 M(+16.5%) | -$20.24 M(-22.6%) |
| Sep 2023 | - | -$4.41 M(-33.0%) | -$26.14 M(+1.4%) |
| Jun 2023 | - | -$6.59 M(+60.7%) | -$25.77 M(-29.4%) |
| Mar 2023 | - | -$4.10 M(-62.9%) | -$36.51 M(-9.9%) |
| Dec 2022 | -$40.52 M(-47.7%) | -$11.05 M(+173.3%) | -$40.52 M(-8.3%) |
| Sep 2022 | - | -$4.04 M(-76.7%) | -$44.19 M(-8.6%) |
| Jun 2022 | - | -$17.32 M(+113.5%) | -$48.35 M(-37.0%) |
| Mar 2022 | - | -$8.11 M(-44.9%) | -$76.70 M(-1.0%) |
| Dec 2021 | -$77.51 M(+138.9%) | -$14.71 M(+79.5%) | -$77.51 M(+10.3%) |
| Sep 2021 | - | -$8.20 M(-82.0%) | -$70.24 M(-1.1%) |
| Jun 2021 | - | -$45.67 M(+412.1%) | -$71.02 M(+103.7%) |
| Mar 2021 | - | -$8.92 M(+19.7%) | -$34.87 M(+7.5%) |
| Dec 2020 | -$32.44 M(+20.2%) | -$7.45 M(-17.0%) | -$32.44 M(+0.7%) |
| Sep 2020 | - | -$8.97 M(-5.8%) | -$32.23 M(+6.5%) |
| Jun 2020 | - | -$9.53 M(+46.8%) | -$30.28 M(+11.8%) |
| Mar 2020 | - | -$6.49 M(-10.3%) | -$27.07 M(+0.3%) |
| Dec 2019 | -$26.98 M(+41.1%) | -$7.24 M(+3.1%) | -$26.98 M(-3.7%) |
| Sep 2019 | - | -$7.02 M(+11.1%) | -$28.02 M(+14.5%) |
| Jun 2019 | - | -$6.32 M(-1.3%) | -$24.46 M(+15.9%) |
| Mar 2019 | - | -$6.40 M(-22.6%) | -$21.10 M(+10.3%) |
| Dec 2018 | -$19.12 M(+15.3%) | -$8.28 M(+138.7%) | -$19.12 M(+127.9%) |
| Sep 2018 | - | -$3.47 M(+17.1%) | -$8.39 M(-13.6%) |
| Jun 2018 | - | -$2.96 M(-33.1%) | -$9.71 M(-24.6%) |
| Mar 2018 | - | -$4.42 M(-279.9%) | -$12.89 M(-22.3%) |
| Dec 2017 | -$16.58 M(-55.1%) | $2.46 M(-151.3%) | -$16.58 M(-33.8%) |
| Sep 2017 | - | -$4.79 M(-21.9%) | -$25.03 M(-10.5%) |
| Jun 2017 | - | -$6.14 M(-24.4%) | -$27.96 M(-12.1%) |
| Mar 2017 | - | -$8.11 M(+35.4%) | -$31.81 M(-14.0%) |
| Dec 2016 | -$36.97 M(-26.9%) | -$5.99 M(-22.3%) | -$36.97 M(-8.6%) |
| Sep 2016 | - | -$7.71 M(-22.7%) | -$40.47 M(-23.4%) |
| Jun 2016 | - | -$9.99 M(-24.8%) | -$52.81 M(-0.1%) |
| Mar 2016 | - | -$13.28 M(+40.0%) | -$52.89 M(+4.6%) |
| Dec 2015 | -$50.59 M(+28.2%) | -$9.49 M(-52.7%) | -$50.59 M(+0.1%) |
| Sep 2015 | - | -$20.06 M(+99.3%) | -$50.53 M(+24.4%) |
| Jun 2015 | - | -$10.07 M(-8.2%) | -$40.62 M(+1.4%) |
| Mar 2015 | - | -$10.97 M(+16.3%) | -$40.05 M(+1.5%) |
| Dec 2014 | -$39.46 M(-9.8%) | -$9.43 M(-7.1%) | -$39.46 M(-4.1%) |
| Sep 2014 | - | -$10.15 M(+7.0%) | -$41.16 M(-4.0%) |
| Jun 2014 | - | -$9.49 M(-8.6%) | -$42.88 M(+2.9%) |
| Mar 2014 | - | -$10.38 M(-6.7%) | -$41.67 M(-4.7%) |
| Dec 2013 | -$43.74 M(+17.4%) | -$11.13 M(-6.2%) | -$43.74 M(-1.6%) |
| Sep 2013 | - | -$11.87 M(+43.3%) | -$44.48 M(+4.4%) |
| Jun 2013 | - | -$8.28 M(-33.5%) | -$42.60 M(+2.8%) |
| Mar 2013 | - | -$12.46 M(+5.0%) | -$41.45 M(+6.3%) |
| Dec 2012 | -$37.26 M(+77.9%) | -$11.86 M(+18.7%) | -$39.01 M(+32.3%) |
| Sep 2012 | - | -$10.00 M(+40.1%) | -$29.47 M(+14.9%) |
| Jun 2012 | - | -$7.13 M(-28.7%) | -$25.65 M(+3.0%) |
| Mar 2012 | - | -$10.01 M(+329.7%) | -$24.89 M(+18.9%) |
| Dec 2011 | -$20.94 M(+11.3%) | -$2.33 M(-62.2%) | -$20.94 M(+16.8%) |
| Sep 2011 | - | -$6.17 M(-3.3%) | -$17.93 M(-0.2%) |
| Jun 2011 | - | -$6.38 M(+5.3%) | -$17.96 M(+0.9%) |
| Mar 2011 | - | -$6.06 M(-993.7%) | -$17.81 M(-5.3%) |
| Dec 2010 | -$18.82 M(-35.5%) | $678.00 K(-110.9%) | -$18.82 M(-25.9%) |
| Sep 2010 | - | -$6.20 M(-0.4%) | -$25.40 M(-2.8%) |
| Jun 2010 | - | -$6.23 M(-11.8%) | -$26.14 M(-5.1%) |
| Mar 2010 | - | -$7.07 M(+19.7%) | -$27.56 M(-5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$29.20 M(-24.0%) | -$5.90 M(-15.0%) | -$29.20 M(-7.6%) |
| Sep 2009 | - | -$6.95 M(-9.1%) | -$31.59 M(-9.9%) |
| Jun 2009 | - | -$7.64 M(-12.2%) | -$35.04 M(-6.3%) |
| Mar 2009 | - | -$8.70 M(+5.0%) | -$37.41 M(-2.6%) |
| Dec 2008 | -$38.39 M(-3.9%) | -$8.29 M(-20.3%) | -$38.39 M(-9.2%) |
| Sep 2008 | - | -$10.40 M(+3.8%) | -$42.28 M(+2.6%) |
| Jun 2008 | - | -$10.02 M(+3.4%) | -$41.21 M(-0.6%) |
| Mar 2008 | - | -$9.69 M(-20.5%) | -$41.46 M(+3.8%) |
| Dec 2007 | -$39.95 M(-5.1%) | -$12.18 M(+30.5%) | -$39.95 M(+11.9%) |
| Sep 2007 | - | -$9.33 M(-9.0%) | -$35.71 M(+4.1%) |
| Jun 2007 | - | -$10.26 M(+25.5%) | -$34.31 M(+1.0%) |
| Mar 2007 | - | -$8.18 M(+2.9%) | -$33.98 M(-19.3%) |
| Dec 2006 | -$42.10 M(-1.0%) | -$7.95 M(+0.2%) | -$42.10 M(-10.3%) |
| Sep 2006 | - | -$7.93 M(-20.2%) | -$46.93 M(-5.1%) |
| Jun 2006 | - | -$9.94 M(-39.0%) | -$49.47 M(0.0%) |
| Mar 2006 | - | -$16.30 M(+27.6%) | -$49.47 M(+16.4%) |
| Dec 2005 | -$42.51 M(+12.1%) | -$12.77 M(+21.9%) | -$42.51 M(+2.2%) |
| Sep 2005 | - | -$10.47 M(+5.4%) | -$41.60 M(+5.4%) |
| Jun 2005 | - | -$9.94 M(+6.5%) | -$39.47 M(+2.8%) |
| Mar 2005 | - | -$9.33 M(-21.3%) | -$38.39 M(+1.3%) |
| Dec 2004 | -$37.91 M(+55.1%) | -$11.86 M(+42.1%) | -$37.91 M(+9.2%) |
| Sep 2004 | - | -$8.35 M(-5.7%) | -$34.71 M(+6.3%) |
| Jun 2004 | - | -$8.85 M(+0.0%) | -$32.63 M(+13.8%) |
| Mar 2004 | - | -$8.85 M(+2.2%) | -$28.67 M(+17.3%) |
| Dec 2003 | -$24.43 M(+35.6%) | -$8.66 M(+38.1%) | -$24.44 M(+15.9%) |
| Sep 2003 | - | -$6.27 M(+28.4%) | -$21.08 M(+7.8%) |
| Jun 2003 | - | -$4.88 M(+5.8%) | -$19.55 M(+2.1%) |
| Mar 2003 | - | -$4.62 M(-13.0%) | -$19.14 M(+6.2%) |
| Dec 2002 | -$18.02 M(+50.7%) | -$5.31 M(+12.0%) | -$18.02 M(+5.5%) |
| Sep 2002 | - | -$4.74 M(+5.9%) | -$17.09 M(+15.4%) |
| Jun 2002 | - | -$4.48 M(+27.9%) | -$14.81 M(+13.0%) |
| Mar 2002 | - | -$3.50 M(-20.0%) | -$13.10 M(+9.5%) |
| Dec 2001 | -$11.96 M(+0.5%) | -$4.37 M(+78.0%) | -$11.96 M(-17.2%) |
| Sep 2001 | - | -$2.46 M(-11.3%) | -$14.45 M(+5.8%) |
| Jun 2001 | - | -$2.77 M(+17.4%) | -$13.66 M(+4.2%) |
| Mar 2001 | - | -$2.36 M(-65.6%) | -$13.11 M(+7.3%) |
| Dec 2000 | -$11.90 M(+132.7%) | -$6.86 M(+311.9%) | -$12.21 M(+83.3%) |
| Sep 2000 | - | -$1.67 M(-24.9%) | -$6.66 M(+17.0%) |
| Jun 2000 | - | -$2.22 M(+51.0%) | -$5.70 M(+21.8%) |
| Mar 2000 | - | -$1.47 M(+11.9%) | -$4.68 M(-9.6%) |
| Dec 1999 | -$5.11 M(-34.5%) | -$1.31 M(+87.4%) | -$5.17 M(-13.2%) |
| Sep 1999 | - | -$700.00 K(-41.6%) | -$5.96 M(-7.7%) |
| Jun 1999 | - | -$1.20 M(-38.9%) | -$6.46 M(-14.6%) |
| Mar 1999 | - | -$1.96 M(-6.5%) | -$7.56 M(-3.0%) |
| Dec 1998 | -$7.80 M(+25.8%) | -$2.10 M(+75.0%) | -$7.80 M(-25.7%) |
| Sep 1998 | - | -$1.20 M(-47.8%) | -$10.50 M(+10.5%) |
| Jun 1998 | - | -$2.30 M(+4.5%) | -$9.50 M(+1.1%) |
| Mar 1998 | - | -$2.20 M(-54.2%) | -$9.40 M(+20.5%) |
| Dec 1997 | -$6.20 M(+158.3%) | -$4.80 M(+2299.5%) | -$7.80 M(+105.2%) |
| Sep 1997 | - | -$200.00 K(-90.9%) | -$3.80 M(-11.6%) |
| Jun 1997 | - | -$2.20 M(+266.7%) | -$4.30 M(+79.2%) |
| Mar 1997 | - | -$600.00 K(-25.0%) | -$2.40 M(+9.1%) |
| Dec 1996 | -$2.40 M(0.0%) | -$800.00 K(+14.3%) | -$2.20 M(-43.6%) |
| Sep 1996 | - | -$700.00 K(+133.3%) | -$3.90 M(+25.8%) |
| Jun 1996 | - | -$300.00 K(-25.0%) | -$3.10 M(-16.2%) |
| Mar 1996 | - | -$400.00 K(-84.0%) | -$3.70 M(+2.8%) |
| Dec 1995 | -$2.40 M | -$2.50 M(-2600.0%) | -$3.60 M(+227.3%) |
| Sep 1995 | - | $100.00 K(-111.1%) | -$1.10 M(-8.3%) |
| Jun 1995 | - | -$900.00 K(+200.0%) | -$1.20 M(+300.0%) |
| Mar 1995 | - | -$300.00 K | -$300.00 K |
FAQ
- What is Windtree Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Windtree Therapeutics?
- What is Windtree Therapeutics annual EBIT year-on-year change?
- What is Windtree Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly EBIT year-on-year change?
- What is Windtree Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Windtree Therapeutics?
- What is Windtree Therapeutics TTM EBIT year-on-year change?
What is Windtree Therapeutics annual earnings before interest & taxes?
The current annual EBIT of WINT is -$20.24 M
What is the all time high annual EBIT for Windtree Therapeutics?
Windtree Therapeutics all-time high annual earnings before interest & taxes is -$2.40 M
What is Windtree Therapeutics annual EBIT year-on-year change?
Over the past year, WINT annual earnings before interest & taxes has changed by +$20.28 M (+50.05%)
What is Windtree Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of WINT is -$2.94 M
What is the all time high quarterly EBIT for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly earnings before interest & taxes is $10.35 M
What is Windtree Therapeutics quarterly EBIT year-on-year change?
Over the past year, WINT quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Windtree Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of WINT is -$9.45 M
What is the all time high TTM EBIT for Windtree Therapeutics?
Windtree Therapeutics all-time high TTM earnings before interest & taxes is -$300.00 K
What is Windtree Therapeutics TTM EBIT year-on-year change?
Over the past year, WINT TTM earnings before interest & taxes has changed by $0.00 (0.00%)